Therapy Approach for PD-L1 Over 50% Lung Cancer
Key opinion leaders consider mono- and combination therapy approaches for patients with PD-L1 (programmed death-ligand 1) status greater than 50%.
OncLiveTV
The Lancet Oncology Commission: Future Cancer Research Priorities in the USA — Part 1
The Lancet Oncology Commission: Future Cancer Research Priorities in the USA — Part 2 Top scientists discuss how they recommend expanding and ...
Johns Hopkins Medicine
PCRI Advanced Prostate Cancer (Royal Stage) Webinar and Live Q&A
OCTOBER 30, 2019 | 5:30 PM PDT | 8:30 PM EDT PCRI's Executive Director, Mark Scholz, MD will be giving a presentation on advanced prostate cancer ...
Prostate Cancer Research Institute
Oncolytic Virotherapy Basic Knowledge Review - Creative Biolabs
Oncolytic viruses（OVs） are viral strains that can infect and kill malignant cells without harming normal cells, while simultaneously stimulate the immune system ...
Creative Biolabs
Cell Penetrating Peptides in Cancer Therapy
Topic: Enhanced Tumor Delivery of RNAi Polyplexes by Histidine-rich Peptide Carriers Conducting research in cancer therapeutics? Have you considered using ...
GenScript USA Inc.
New in Targeted Therapies
This video provides a look at the latest targeted therapy research to help you understand how it applies to your own care and ongoing health concerns. You'll ...
Living Beyond Breast Cancer
Dr. Shaughnessy on Challenges With CAR T-Cell Therapy in Hematologic Malignancies
Paul J. Shaughnessy, MD, discusses challenges with CAR T-cell therapy in relapsed/refractory hematologic malignancies. Website: https://www.onclive.com ...
OncLiveTV
The Future of Pancreatic Cancer Research and Treatment
On November 29, NCI's Dr. Christine Alewine participated in a Facebook Live event with Lynn Matrisian, Ph.D., Chief Research Officer of the Pancreatic Cancer ...
National Cancer Institute
Second line Bladder Cancer Therapies When First Line Treatments Fail
Jennifer M. Taylor, MD, MPH, discusses risk-stratification in non-muscle invasive bladder cancer (NMIBC), definitions of treatment failure in this setting, and ...
Grand Rounds in Urology
Live Webchat: Cervical Cancer Treatment, Research and Prevention
Join Ursula Matulonis, MD, director of the Gynecologic Oncology Program at the Susan F. Smith Center for Women's Cancers at Dana-Farber, and Alexi Wright, ...
Dana-Farber Cancer Institute
Upfront Therapy Approaches in Gastric/GEJ Cancer
Yelena Y. Janjigian, MD; Zev A. Wainberg, MD; and Alan P. Venook, MD, share insight on the upfront approaches and goals of therapy concerning the treatment ...
OncLiveTV
Dr. Hamilton on the Evolution of Treatment in HER2+ Breast Cancer
Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: ...
OncLiveTV
The Latest Research in Gastrointestinal Cancer Treatment | Dana-Farber Cancer Institute
Adam Bass, MD, of Dana-Farber's Gastrointestinal Cancer Treatment Center, discusses some of the new research in treating GI cancers, including ...
Dana-Farber Cancer Institute
Prechemotherapy Treatment Strategies in Castration-Resistant Prostate Cancer
In this segment, panelists discuss the current definition of castration-resistant prostate cancer and the variety of treatment options that are available for patients ...
OncLiveTV
Future Directions for Treating Advanced Ovarian Cancers
Panelists Bradley J. Monk, MD; Angeles Alvarez Secord, MD; Kathleen N. Moore, MD; Robert L. Coleman, MD; and Thomas Herzog, MD, outline their thoughts ...
OncLiveTV
Improving the Management of Metastatic Breast Cancer: Novel and Emerging Treatments, Part I
Metastatic breast cancer represents a challenging treatment landscape that has witnessed the approval of multiple new therapies in recent years. Novel ...
OncLiveTV
Combination therapies in cancer treatment – Video abstract [ID 61292]
Video abstract of a review paper “Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment” published in the open access ...
Dove Medical Press
Metastatic gastric cancer: Where are we with check-point inhibitors in gastric cancer?
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Kei Muro discusses checkpoint inhibitors in metastatic cancer.
ImedexCME
Vincristine in Acute Lymphoblastic Leukemia
In this segment, Dan Douer, MD, and Mark R. Litzow, MD, discuss vincristine sulfate liposome injection, Marqibo.
OncLiveTV
AUGMENTING YOUR IMMUNITY | Peter Diamandis X Celularity CEO Dr. Bob Hariri
Augmenting your immunity is key to fighting COVID-19. ⠀⠀⠀⠀⠀⠀⠀⠀⠀ Dr. Bob Hariri and the science team at Celularity Inc. have developed ability to expand ...
Peter H. Diamandis
TRACO 2018 - Pancreatic cancer and Nanotechnology
TRACO 2018 - Pancreatic cancer and Nanotechnology Air date: Monday, December 3, 2018, 4:00:00 PM Category: TRACO Runtime: 01:17:24 Description: ...
NIH VideoCast
At the Leading Edge of Breast Cancer Research: Immuno-Oncology
Leaders of Dana-Farber's Susan F. Smith Center for Women's Cancers share updates on their groundbreaking work in immunotherapies and how this work is ...
Dana-Farber Cancer Institute
Recent Advances in Pancreatic Cancer Research
John L. Marshall, MD; Kenneth H. Yu, MD; and Fadi Braiteh, MD, provide an overview of recent advances in the field of pancreatic cancer, including an ...
OncLiveTV
Follicular Lymphoma: Changes in the Treatment Landscape
Experts Bruce Cheson, MD; Nathan Fowler, MD; and Anas Younes, MD, discuss the most recent challenges and advancements in Follicular Lymphoma, ...
OncLiveTV
Flavor Aversion Learning in Cancer Treatment | Robert Batsell | TEDxKalamazooCollege
Dr. Batsell looks at the principles of flavor aversion learning, and helps portray their implications in cancer treatment - primarily chemotherapy. Robert 'Bob' ...
TEDx Talks
Acute Lymphoblastic Leukemia: Risk Stratification
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk ...
OncLiveTV
Stanford Dietitian Discusses Nutrition and Cancer Myths and Legends
Nutrition and Cancer: Myths and Legends When someone is diagnosed with cancer, the search for accurate information can be quite daunting. People want to ...
Stanford Health Care
Approaching Treatment for Relapsed/Refractory ALL
Mark R. Litzow, MD; Anthony S. Stein, MD; Bijal D. Shah, MD; Aaron C. Logan, MD, PhD; and Ryan D. Cassaday, MD, describe individualized approaches for ...
OncLiveTV
Dr. Hurvitz on Eliminating Anthracyclines in HER2+ Breast Cancer Treatment
Sara Hurvitz, MD, Associate Professor of Medicine at UCLA, discusses data supporting the elimination of anthracyclines in HER2-positive breast cancer ...
OncLiveTV
Elotuzumab and Daratumumab in Multiple Myeloma
Kenneth Anderson, MD, explains the mechanisms of action for two new monoclonal antibodies, elotuzumab and daratumumab, currently under investigation for ...
OncLiveTV
Gene Targeted Therapy for Non Small Cell Lung Cancer
Dr. Igor I Rybkin.
Chief Fellow
Acute GI Bleeding, Oral Anticoagulant Therapy, and Reversal Strategies
Earn CME: https://www.naccme.com/program/7337-1 In this webcast from the 'Addressing GI Bleeds and Mitigating Risk: Focus on DOAC Reversal and ...
ImedexCME
Phase 3 trial results suggest potential new treatment approach for prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr Neal Shore of Atlantic Urology Clinics, Myrtle Beach, SC, reviews the current ...
Patient Power Europe
Don Kohn: CRISPR Applications - Gene Editing in Hematopoietic Stem Cells
Don Kohn (University of California, Los Angeles) describes the use of gene editing in hematopoietic stem cells and applications to treat various blood-related ...
Innovative Genomics Institute – IGI
Understanding Breast Cancer Biology: New Discoveries and Treatments
Dr. Mark Pegram gives an update on the development of new therapeutics and the role of clinical trials in improving the quality and quantity of life for patients.
Stanford Medicine
Novel Targeted Approaches in Gastroesophageal Cancer
Johanna C. Bendell, MD; Yelena Y. Janjigian, MD; Kohei Shitara, MD; Eric Van Cutsem, MD, PhD, and Peter C. Enzinger, MD, examine novel targeted ...
OncLiveTV
Late Effects of Pediatric Cancer Therapy
MGMC Grand Rounds 4-18-12 Nicholas Fustino, MD Pediatric Hematology/Oncology Blank Children's Hospital.
Mary Greeley Medical Center
Managing EGFR Inhibitor Associated Skin Toxicity
Mario E. Lacouture, MD, a dermatologist at Memorial Sloan-Kettering Cancer Center, describes the management of dermatologic adverse events that occur as a ...
OncLiveTV
Advances in CAR T cell manufacture – Bridging the commercialization gaps
CAR T cell therapies are a promising approach in the treatment of cancer. However, on the way to providing these treatments on a large scale, critical gaps need ...
Miltenyi Biotec
Treatment with Radioactive Iodine
Michael Tuttle, MD and Matthew Taylor, MD describe the risk stratification approach for use of radioactive iodine on the endocrine and nuclear medicine side of ...
OncLiveTV
Treatment of Metastatic Melanoma: Could Timing Be Everything?
Svetomir Markovic, M.D., Ph.D., explains how his research at the Mayo Clinic, which is focused on understanding opportunities to integrate different systemic ...
Mayo Clinic
MD vs. Machine: Artificial intelligence in health care
Recent advances in artificial intelligence and machine learning are changing the way doctors practice medicine. Can medical data actually improve health care?
Harvard Medical School
